The Asia Pacific Steerable Sheaths Market would witness market growth of 7.5% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Steerable Sheaths Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $89.8 million by 2031. The Japan market is showcasing a CAGR of 6.8% during (2024 - 2031). Additionally, The India market would register a CAGR of 8.2% during (2024 - 2031).
In electrophysiology (EP) procedures, such as cardiac ablation for arrhythmias, steerable sheaths enable precise catheter manipulation and mapping, facilitating accurate lesion formation and targeted therapy delivery. It provides clinicians with enhanced control and manoeuvrability during EP procedures, improving procedural efficacy and reducing recurrence rates.
Furthermore, in urological and gastrointestinal procedures, such as ureteroscopy and endoscopic retrograde cholangiopancreatography (ERCP), it enables clinicians to navigate complex anatomical structures and perform minimally invasive interventions with improved precision and safety. Steerable sheaths enhance procedural efficiency and reduce the risk of iatrogenic injury, enabling clinicians to achieve optimal outcomes in challenging cases.
India is experiencing a rise in obesity, particularly in urban areas, which is associated with an increased risk of CVD. Likewise, the prevalence of diabetes and hypertension, both significant risk factors for CVD, is on the rise in India, partly due to lifestyle changes and genetic predispositions. As the incidence of CVD continues to rise in India, there is a growing need for advanced cardiovascular interventions and surgeries to treat these conditions.
Free Valuable Insights: The Global Steerable Sheaths Market is Predict to reach USD 1.2 Billion by 2031, at a CAGR of 7.0%
Based on Type, the market is segmented into Single-Use Steerable Sheaths and Reprocessed Steerable Sheaths. Based on Application, the market is segmented into Electrophysiology (EP) Procedures, Interventional Cardiology Procedures, Peripheral Vascular Procedures, and Others. Based on End-use, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
By Type
By Application
By End-use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 